liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Expression of IL-1 beta, IL-1 receptor type I and IL-1 receptor antagonist in human aortic smooth muscle cells: Effects of all-trans-retinoic acid
University of Örebro, Sweden.
University of Örebro, Sweden.
University of Örebro, Sweden.
University College of Health Sciences, Jönköping, Sweden.
Show others and affiliations
2006 (English)In: Journal of Vascular Research, ISSN 1018-1172, E-ISSN 1423-0135, Vol. 43, no 4, 377-382 p.Article in journal (Refereed) Published
Abstract [en]

The proinflammatory cytokine interleukin (IL)-1 beta and the IL-1 receptor antagonist are expressed by atherosclerotic plaques and may be linked to the development of atherosclerosis. Existing evidence shows that retinoids and their receptors are involved in inflammatory response and that they are found in atherosclerotic plaques. In all-trans-retinoic acid (atRA)-treated human aortic smooth muscle cells (AOSMC), significant increases in IL-1 beta levels were observed, compared with untreated cells. Examination of IL-1 receptor antagonist and IL-1 receptor type I levels did not show any difference between atRA-treated and -untreated AOSMC. The results show that atRA-treated AOSMC express both the precursor (33 kDa) and the active form (17 kDa) of the IL-1 P protein. atRA-treated carotid lesions showed significantly elevated IL-1 beta mRNA levels (2.9 +/- 2.33) compared with untreated lesions (2.0 +/- 1.77; p less than 0.05). These results support the role of atRA as a regulator of inflammation such as in atherosclerosis.

Place, publisher, year, edition, pages
S. Karger, 2006. Vol. 43, no 4, 377-382 p.
Keyword [en]
caspase 1; interleukin; inflammation; vitamin A; atherosclerosis; smooth muscle cells
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-100356DOI: 10.1159/000094258ISI: 000239390100008OAI: oai:DiVA.org:liu-100356DiVA: diva2:661607
Available from: 2013-11-04 Created: 2013-11-04 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Wågsäter, Dick

Search in DiVA

By author/editor
Wågsäter, Dick
In the same journal
Journal of Vascular Research
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 53 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf